Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DCC-2036 (Rebastinib)

InhA, Func 1020172-07-9
N° du produit ABIN4878278

Aperçu rapide pour DCC-2036 (Rebastinib) (ABIN4878278)

Application

Inhibition Assay (InhA), Functional Studies (Func)
  • Fonction

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Attributs du produit

    Target: Bcr-Abl inhibitor
    Receptor: Abl1,FLT3,KDR,Tie-2,Lyn,Src

    Purification

    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.

    Pureté

    99.70 %

    Formula

    C30H28FN7O3

    Solubility

    200 mM in DMSO
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Solid

    Stock

    -20 °C

    Stockage commentaire

    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.

    Date de péremption

    24 months
  • Sujet

    Angiogenesis

    Poids moléculaire

    553.59 g/mol

    Numéro CAS

    1020172-07-9
Vous êtes ici:
Chat with us!